HTR3A and substance withdrawal syndrome: 5-HT3A antagonism has an antiemetic effect [23] and may decrease the behavioral consequences of withdrawal syndromes caused by the treatment of drugs of abuse and for several psychiatric disorders (e.g., psychoses, anxiety, and cognitive dysfunction) [28,33]